13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q2 2025 · Filed July 8, 2025 · Accession 0000950123-25-006205
Total Value
$427.3M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $262.3M | 61.40% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $71.6M | 16.75% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $52.0M | 12.16% |
| 4 | RAPT THERAPEUTICS INC | 75382E208 | 2,794,000 | $22.4M | 5.23% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $19.0M | 4.45% |